Skip to main content
PolicySpeak
← All files
ISC

IRCCS Sacro Cuore - Istituto Don Calabria

Academic / research · Italy

3
positions filed
in the 583 files tracked
1
legislative file
of 583 tracked
1
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Track IRCCS in PolicySpeak: request access →

Work at IRCCS Sacro Cuore - Istituto Don Calabria? so we know who speaks for it.

Follow the file IRCCS Sacro Cuore - Istituto Don Calabria engages with

One email on Tuesdays when a new position is filed on this file, from IRCCS Sacro Cuore - Istituto Don Calabria or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

IRCCS Sacro Cuore - Istituto Don Calabria filed 3 positions between 30 Oct 2023 and 8 Nov 2023, across 1 of the 583 legislative files tracked here, attaching a full position paper 1 time.

What they argued

Medicinal products for human usefiled 8 Nov 2023source

The labeling of the primary packaging (vial) of radiopharmaceuticals is a practice that involves investigative procedures for the manufacturer, with onerous repercussions (procedural and structural). We know that for radiation protection issues, the vial containing radiopharmaceutical cannot be handled so the label on the vial cannot be read by practitioners in Nuclear Medicine, at least as long as it is…

Medicinal products for human usefiled 31 Oct 2023source

The labeling of the primary packaging (vial) of radiopharmaceuticals is a practice that involves investigative procedures for the manufacturer, with onerous repercussions (procedural and structural). We know that for radiation protection issues, the vial containing radiopharmaceutical cannot be handled so the label on the vial cannot be read by practitioners in Nuclear Medicine, at least as long as it is…

Medicinal products for human usefiled 30 Oct 2023PDFsource

Comment on Article 68 The labelling of the immediate packaging of radiopharmaceuticals (in particular those used in PET) is a practice which increases the risks and does not bring any clinical or safety benefit to the user.

Filed in Italian · English published by the European Commission

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put IRCCS Sacro Cuore - Istituto Don Calabria next to another organization. Same files, same register facts, side by side. Compare →

Is this your organization?

Everything on this page comes from IRCCS Sacro Cuore - Istituto Don Calabria’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.